Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 734

1.

Chemical characterization of synthetic cannabinoids by electrospray ionization FT-ICR mass spectrometry.

Kill JB, Oliveira IF, Tose LV, Costa HB, Kuster RM, Machado LF, Correia RM, Rodrigues RR, Vasconcellos GA, Vaz BG, Romão W.

Forensic Sci Int. 2016 Jul 19;266:474-487. doi: 10.1016/j.forsciint.2016.07.007. [Epub ahead of print]

PMID:
27471991
2.

Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.

Nia AB, Medrano B, Perkel C, Galynker I, Hurd YL.

J Psychopharmacol. 2016 Jul 26. pii: 0269881116658990. [Epub ahead of print]

PMID:
27462088
3.

Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.

Abouchedid R, Ho JH, Hudson S, Dines A, Archer JR, Wood DM, Dargan PI.

J Med Toxicol. 2016 Jul 25. [Epub ahead of print]

PMID:
27456262
4.

A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes.

Blevins CE, Banes KE, Stephens RS, Walker DD, Roffman RA.

Addict Behav. 2016 Jul 8;63:114-119. doi: 10.1016/j.addbeh.2016.07.005. [Epub ahead of print]

PMID:
27454353
5.

Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.

Wiley JL, Lefever TW, Marusich JA, Grabenauer M, Moore KN, Huffman JW, Thomas BF.

Neuropharmacology. 2016 Jul 20;110(Pt A):143-153. doi: 10.1016/j.neuropharm.2016.07.016. [Epub ahead of print]

PMID:
27449567
6.

Cannabinoids, inflammation, and fibrosis.

Zurier RB, Burstein SH.

FASEB J. 2016 Jul 19. pii: fj.201600646R. [Epub ahead of print] Review.

PMID:
27435265
7.

Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice.

Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE.

Forensic Toxicol. 2016;34:329-343. Epub 2016 May 17.

8.

Cannabinoids for fibromyalgia.

Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W.

Cochrane Database Syst Rev. 2016 Jul 18;7:CD011694. [Epub ahead of print] Review.

PMID:
27428009
9.

Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence.

Ninnemann AL, Lechner WV, Borges A, Lejuez CW.

Addict Behav. 2016 Jul 8;63:72-73. doi: 10.1016/j.addbeh.2016.07.004. [Epub ahead of print]

PMID:
27424166
10.

Acute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015.

Riederer AM, Campleman SL, Carlson RG, Boyer EW, Manini AF, Wax PM, Brent JA; Toxicology Investigators Consortium (ToxIC).

MMWR Morb Mortal Wkly Rep. 2016 Jul 15;65(27):692-5. doi: 10.15585/mmwr.mm6527a2.

11.

Quantification of synthetic cannabinoids in herbal smoking blends using NMR.

Dunne SJ, Rosengren-Holmberg JP.

Drug Test Anal. 2016 Jul 12. doi: 10.1002/dta.2032. [Epub ahead of print]

PMID:
27400773
12.

The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.

Bow EW, Rimoldi JM.

Perspect Medicin Chem. 2016 Jun 28;8:17-39. doi: 10.4137/PMC.S32171. eCollection 2016.

13.

Unusual side effect of cannabis use: acute abdomen due to duodenal perforation.

Buyukbese Sarsu S.

Int J Emerg Med. 2016 Dec;9(1):18. doi: 10.1186/s12245-016-0114-7. Epub 2016 Jul 7.

14.

Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.

Shalit N, Barzilay R, Shoval G, Shlosberg D, Mor N, Zweigenhaft N, Weizman A, Krivoy A.

J Clin Psychiatry. 2016 Jul 5. doi: 10.4088/JCP.15m09938. [Epub ahead of print]

PMID:
27379411
15.

[Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report].

Sönmez İ, Köşger F.

Turk Psikiyatri Derg. 2016 Spring;27(1):63-6. Turkish.

16.

Understanding the Link Between Cannabinoids and Psychosis.

Rabin RA, George TP.

Clin Pharmacol Ther. 2016 Jul 1. doi: 10.1002/cpt.421. [Epub ahead of print] No abstract available.

PMID:
27367612
17.

Synthetic Cannabinoid 'Bonzai' Intoxication: Six Case Series.

Ergül DF, Ekemen S, Yelken BB.

Turk J Anaesthesiol Reanim. 2015 Oct;43(5):347-51. doi: 10.5152/TJAR.2015.05668. Epub 2015 Aug 21.

18.

Regulating tobacco retail in New Zealand: what can we learn from overseas?

Robertson L, Marsh L, Edwards R, Hoek J, van der Deen FS, McGee R.

N Z Med J. 2016 Apr 1;129(1432):74-9.

PMID:
27356255
19.

Guidance is needed on synthetic cannabinoid receptor agonists and cannabis.

Hamilton I.

BMJ. 2016 Jun 28;353:i3491. doi: 10.1136/bmj.i3491. No abstract available.

PMID:
27353736
20.

Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.

Barbieri M, Ossato A, Canazza I, Trapella C, Borelli AC, Beggiato S, Rimondo C, Serpelloni G, Ferraro L, Marti M.

Neuropharmacology. 2016 Jun 23;109:254-269. doi: 10.1016/j.neuropharm.2016.06.027. [Epub ahead of print]

PMID:
27346209
Items per page

Supplemental Content

Loading ...
Write to the Help Desk